TENTH OF RAMADAN FOR PHARMACEUTICAL INDUSTRIES AND DIAGNOSTIC REAGENTS (RAMEDA) EGX:RMDA:
Q3 NET INCOME EGP 96 MILLION
Q3 REVENUE EGP 1.14 BILLION
Egypt's Rameda Q3 Income EGP 96 Mln
Tenth of Ramadan Pharmaceutical Industries & Diagnostic-Rameda on 6ix
Earlier from Tenth of Ramadan Pharmaceutical Industries & Diagnostic-Rameda
- Egypt's Rameda Borad Proposes To Increase Issued Capital
- SNG: Egypt: Rameda reports 44.3% YoY consolidated profit decline in Q1 2025
- Egypt's Rameda Reports Q1 Profit EGP 85.9 Mln
- SNG: Egypt: Rameda to pay $3.15mln cash dividends for 2024
Later from Tenth of Ramadan Pharmaceutical Industries & Diagnostic-Rameda
- LVP Pharma Raises Stake In RAMEDA To 11.8% - EGX
- LVP Pharma Raises Stake In RAMEDA To 23.15% - EGX
- Rameda FY Consol Profit EGP 313.2 Million
- Egypt's Rameda Q1 Standalone Profit EGP 105.2 Million
- Egypt's RAMEDA Appoints Sherif Ahmed Mohamed El Akhdar As Chairman
Follow Tenth of Ramadan Pharmaceutical Industries & Diagnostic-Rameda into a list and get an email when it puts out news.
Follow Tenth of Ramadan Pharmaceutical Industries & Diagnostic-Rameda